References:
1. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for
the management of infective endocarditis: The Task Force for the
Management of Infective Endocarditis of the European Society of
Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic
Surgery (EACTS), the European Association of Nuclear Medicine (EANM).Eur Heart J. 2015;36(44):3075-3128.
2. Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRA expert consensus
statement on lead extraction: recommendations on definitions, endpoints,
research trial design, and data collection requirements for clinical
scientific studies and registries: endorsed by APHRS/HRS/LAHRS.Europace. 2018;20(7):1217.
3. Olsen T, Jorgensen OD, Nielsen JC, Thogersen AM, Philbert BT,
Johansen JB. Incidence of device-related infection in 97 750 patients:
clinical data from the complete Danish device-cohort (1982-2018).Eur Heart J. 2019;40(23):1862-1869.
4. Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with
pacemaker or implantable cardioverter-defibrillator generator
replacements and upgrade procedures: results from the REPLACE registry.Circulation. 2010;122(16):1553-1561.
5. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus
bacteremia in patients with permanent pacemakers or implantable
cardioverter-defibrillators. Circulation. 2001;104(9):1029-1033.
6. Maskarinec SA, Thaden JT, Cyr DD, Ruffin F, Souli M, Fowler VG. The
Risk of Cardiac Device-Related Infection in Bacteremic Patients Is
Species Specific: Results of a 12-Year Prospective Cohort. Open
Forum Infect Dis. 2017;4(3):ofx132.
7. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert
consensus statement on cardiovascular implantable electronic device lead
management and extraction. Heart Rhythm. 2017;14(12):e503-e551.
8. Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18
positron emission tomography/computed tomography for identification of
cardiovascular implantable electronic device infections. J Am Coll
Cardiol. 2012;59(18):1616-1625.
9. Graziosi M, Nanni C, Lorenzini M, et al. Role of (1)(8)F-FDG PET/CT
in the diagnosis of infective endocarditis in patients with an implanted
cardiac device: a prospective study. Eur J Nucl Med Mol Imaging.2014;41(8):1617-1623.
10. Bensimhon L, Lavergne T, Hugonnet F, et al. Whole body [(18)
F]fluorodeoxyglucose positron emission tomography imaging for the
diagnosis of pacemaker or implantable cardioverter defibrillator
infection: a preliminary prospective study. Clin Microbiol
Infect. 2011;17(6):836-844.
11. Reynolds D, Duray GZ, Omar R, et al. A Leadless Intracardiac
Transcatheter Pacing System. N Engl J Med. 2016;374(6):533-541.
12. El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of
the Micra transcatheter pacemaker in the real-world setting: A
comparison to the investigational study and a transvenous historical
control. Heart Rhythm. 2018;15(12):1800-1807.
13. Satoh T, Fukui A, Katoh S, Matsui M. A Leadless Pacemaker Which
Became Encapsulated Only Two Months after Placement. Intern Med.2018;57(20):3053-3054.
14. Kypta A, Blessberger H, Lichtenauer M, Steinwender C. Complete
encapsulation of a leadless cardiac pacemaker. Clin Res Cardiol.2016;105(1):94.
15. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC
Guidelines on cardiac pacing and cardiac resynchronization therapy: the
Task Force on cardiac pacing and resynchronization therapy of the
European Society of Cardiology (ESC). Developed in collaboration with
the European Heart Rhythm Association (EHRA). Eur Heart J.2013;34(29):2281-2329.
16. Greenspon AJ, Rhim ES, Mark G, Desimone J, Ho RT. Lead-associated
endocarditis: the important role of methicillin-resistant Staphylococcus
aureus. Pacing Clin Electrophysiol. 2008;31(5):548-553.
17. Nagpal A, Baddour LM, Sohail MR. Microbiology and pathogenesis of
cardiovascular implantable electronic device infections. Circ
Arrhythm Electrophysiol. 2012;5(2):433-441.
18. El-Chami MF, Soejima K, Piccini JP, et al. Incidence and outcomes of
systemic infections in patients with leadless pacemakers: Data from the
Micra IDE study. Pacing Clin Electrophysiol.2019;42(8):1105-1110.
19. El-Chami MF, Johansen JB, Zaidi A, et al. Leadless pacemaker implant
in patients with pre-existing infections: Results from the Micra
postapproval registry. J Cardiovasc Electrophysiol.2019;30(4):569-574.
20. El-Chami MF, Mayotte J, Bonner M, Holbrook R, Stromberg K, Sohail
MR. Reduced bacterial adhesion with parylene coating: Potential
implications for Micra transcatheter pacemakers. J Cardiovasc
Electrophysiol. 2020.
21. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac
implantable electronic device infection: a systematic review and
meta-analysis. Europace. 2015;17(5):767-777.